Workflow
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
ADMAADMA Biologics(ADMA) Zacks Investment Research·2024-05-10 07:21

Adma Biologics (ADMA) came out with quarterly earnings of 0.08pershare,beatingtheZacksConsensusEstimateof0.08 per share, beating the Zacks Consensus Estimate of 0.05 per share. This compares to loss of 0.03pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof600.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 60%. A quarter ago, it was expected that this infectious disease drug developer would post earnings of 0.02 per share when it actually produced earnings of $0.04, delivering a surprise of 100%.Over the last four quarte ...